CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 139 filers reported holding CHINOOK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $11,026,309 | +120.9% | 286,994 | +33.1% | 0.00% | +100.0% |
| Q1 2023 | $4,991,487 | +212.4% | 215,615 | +253.6% | 0.00% | – |
| Q4 2022 | $1,597,755 | -73.0% | 60,983 | -79.8% | 0.00% | -100.0% |
| Q3 2022 | $5,921,000 | -6.4% | 301,170 | -16.7% | 0.00% | -50.0% |
| Q2 2022 | $6,324,000 | +610.6% | 361,600 | +564.3% | 0.00% | – |
| Q1 2022 | $890,000 | -27.8% | 54,435 | -28.0% | 0.00% | – |
| Q4 2021 | $1,232,000 | +142.0% | 75,574 | +89.4% | 0.00% | – |
| Q3 2021 | $509,000 | +24.4% | 39,895 | +37.8% | 0.00% | – |
| Q2 2021 | $409,000 | -39.6% | 28,958 | -33.5% | 0.00% | – |
| Q1 2021 | $677,000 | -65.4% | 43,567 | -64.7% | 0.00% | – |
| Q4 2020 | $1,958,000 | – | 123,336 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |